Click to Translate to English Click to Translate to French  Click to Translate to Spanish  Click to Translate to German  Click to Translate to Italian  Click to Translate to Japanese  Click to Translate to Chinese Simplified  Click to Translate to Korean  Click to Translate to Arabic  Click to Translate to Russian  Click to Translate to Portuguese  Click to Translate to Myanmar (Burmese)

PANDEMIC ALERT LEVEL
123456
Forum Home Forum Home > Main Forums > Latest News
  New Posts New Posts RSS Feed - Covid-19 Vaccine Studies May Suffer
  FAQ FAQ  Forum Search   Events   Register Register  Login Login

Online Discussion: Tracking new emerging diseases and the next pandemic since 2005; Coronavirus COVID-19 Pandemic Discussion Forum.

Covid-19 Vaccine Studies May Suffer

 Post Reply Post Reply
Author
Message
ksc View Drop Down
Adviser Group
Adviser Group


Joined: February 09 2020
Status: Offline
Points: 3625
Post Options Post Options   Thanks (0) Thanks(0)   Quote ksc Quote  Post ReplyReply Direct Link To This Post Topic: Covid-19 Vaccine Studies May Suffer
    Posted: November 27 2020 at 7:39am
Covid-19 Vaccine Studies May Suffer as Volunteers Consider Dropping Out
November 27 2020 - 09:29AM
Dow Jones News

https://ih.advfn.com/stock-market/NASDAQ/astrazeneca-AZN/stock-news/83779431/covid-19-vaccine-studies-may-suffer-as-volunteers

Susan Baker volunteered for Johnson & Johnson's vaccine trial to seek protection from Covid-19. For the same reason, she may drop out of the study.

The nurse practitioner at a North Carolina hospital has treated Covid-19 patients. She takes care of people at high risk, including dialysis patients and her husband and father, both of whom have medical conditions. If she catches the virus and spreads it to anyone vulnerable, "I don't know if I could forgive myself," she said.

That is why Ms. Baker may drop out of J&J's vaccine trial. She took an antibody test indicating she received a placebo instead of the actual vaccine in the study. With positive early results for vaccines from Pfizer Inc. and Moderna Inc. pointing toward use in the U.S. possibly within weeks, she wants to be first in line to get one, though she previously agreed to stick with the study so it could fully vet J&J's injection.

"Anything that could potentially protect you, you want so desperately right now," the 42-year-old said.

Authorization of the most advanced vaccine candidates would mark a turning point in the fight against Covid-19. Yet it might also set back the effort, compromising ongoing vaccine trials, including Pfizer's and Moderna's, by prompting volunteers to quit.

Researchers scheduled two-year trials for the leading vaccines. They didn't plan to tell the volunteers whether they got a shot or placebo until a study ends. Subjects agreed to the terms upon signing up.

Back to Top
 Post Reply Post Reply
  Share Topic   

Forum Jump Forum Permissions View Drop Down